Evidence map›Paper›PMID 26662110›Full record

ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2016

Breast cancer cell line MDA-MB-231 miRNA profile expression after BIK interference: BIK involvement in autophagy.

Ruth Ruiz Esparza-Garrido, María Eugenia Torres-Márquez, Rubí Viedma-Rodríguez, Ana Claudia Velázquez-Wong, Fabio Salamanca-Gómez, Haydeé Rosas-Vargas, Miguel Ángel Velázquez-Flores

Abstract read
PubMed Publisher
In one paragraph

Article in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Cell Death: Mechanisms and Potential Targets in Breast Cancer Therapy.International journal of molecular sciences · 2024
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Ruth Ruiz Esparza-GarridoCONACyT Research Fellow, Functional Genomics Laboratory, Unit of Human Genetics Research, Children's Hospital, National Medical Center Century XXI, Mexican Institute of Social Security (IMSS), México, C.P. 06720, DF, México. uimgeneticahumana@gmail.com.
María Eugenia Torres-MárquezBiochemistry Department, School of Medicine, UNAM, México, 04510, DF, México.
Rubí Viedma-RodríguezLaboratorio de Biología del Desarrollo, Unidad de Morfología y Función Celular, Facultad de Estudios Superiores Iztacala (FES Iztacala), Universidad Nacional Autónoma de México (UNAM-México), 54090, Tlalnepantla, Estado de México, México.
Ana Claudia Velázquez-WongFunctional Genomics Laboratory, Unit of Human Genetics Research, Children's Hospital, National Medical Center Century XXI, Mexican Institute of Social Security (IMSS), México, C.P. 06720, DF, México.
Fabio Salamanca-GómezCoordinación de Investigación en Salud, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, México, DF, México.
Haydeé Rosas-VargasFunctional Genomics Laboratory, Unit of Human Genetics Research, Children's Hospital, National Medical Center Century XXI, Mexican Institute of Social Security (IMSS), México, C.P. 06720, DF, México.
Miguel Ángel Velázquez-FloresFunctional Genomics Laboratory, Unit of Human Genetics Research, Children's Hospital, National Medical Center Century XXI, Mexican Institute of Social Security (IMSS), México, C.P. 06720, DF, México.
Mexican Social Security Institute · MXAutonomous University of Tlaxcala · MXCentro Medico Nacional Siglo XXI · MXUniversidad Nacional Autónoma de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

B-cell lymphoma 2 (BCL2)-interacting killer (apoptosis inducing) (BIK) has been proposed as a tumor suppressor in diverse types of cancers. However, BIK's overexpression in breast cancer (BC) and in non-small lung cancer cells (NSCLCs), associated with a poor prognosis, suggests its participation in tumor progression. In this study, we evaluated the global expression pattern of microRNAs (miRNAs), messenger RNA (mRNA) expression changes in autophagy, and autophagic flux after BIK interference. BIK gene expression was silenced by small interfering RNA (siRNA) in BC cell MDA-MB-231, and BIK interference efficiency was tested by real-time PCR and by Western blotting. BIK expression levels decreased by 75 ± 18 % in the presence of 600 nM siRNA, resulting in the abolishment of BIK expression by 94 ± 30 %. BIK interference resulted in the overexpression of 17 miRNAs that, according to the DIANA-miRPath v3.0 database, are mainly implied in the control of cell signaling, gene expression, and autophagy. The autophagy array revealed downregulation of transcripts which participate in autophagy, and their interactome revealed a complex network, where hepatocyte growth factor-regulated tyrosine kinase substrate (HGS), α-synuclein (SNCA), unc-51-like autophagy activating kinase 1/2 (ULK1/2), and mitogen-activated protein kinase 3 (MAPK3) were shown to be signaling hubs. LC3-II expression-an autophagy marker-was increased by 169 ± 25 % after BIK interference, which indicates the involvement of BIK in autophagy. Altogether, our results indicate-for the first time-that BIK controls the expression of miRNAs, as well as the autophagic flux in MDA-MB-231 cells.

Indexed as

Gene Expression Regulation, NeoplasticRNA InterferenceTranscriptomeApoptosis Regulatory ProteinsAutophagyBreast NeoplasmsCell Line, TumorCluster AnalysisComputational BiologyFemaleGene Expression ProfilingGene Regulatory NetworksHumansMembrane ProteinsMicroRNAsMitochondrial ProteinsApoptosis Regulatory ProteinsBIK protein, humanMembrane ProteinsMicroRNAsMitochondrial ProteinsRNA, MessengerAutophagyBIKInteractomeMDA-MB-231MicroRNAs

Identifiers

PMID26662110
OpenAlexW2290873441

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.